password

username

• Newsletters
• Senders
• Contribute
• Faq

Newsletter preview

Date:

Tue, September 19, 2006 11:15:43 AM

From:

Outsourcing-Pharma

Subject:

19/09 OSP keywords/BMS/Cardinal/Pfizer/Bioinformatics/CRO

Can't read the email below? Click Here

Today on Outsourcing-Pharma.com   >  BMS says outsourcing is 'a strategic function asset'   >  Cardinal gets green light for new sterile facility start-up   >  Kemwell seals Pfizer plant deal   >  Bioinformatics outsourcing poised for growth   >  CROs to benefit from new trial analysis technique

Other top industry news   >  Sieve advances protein separation and drug development   >  Lean proves mean in drug manufacturing   >  Will big pharma share its APIs for the sake of custom-made drugs?   >  Discovery could halt antibiotic resistant spread

	Outsourcing Pharma
Search Forward to a colleague		Tuesday 19 September 2006

	Sponsored by Cardinal Health Cardinal Health enhances drug delivery Cardinal Health is a world leader in patented drug-delivery technologies. We develop and manufacture advanced drug-delivery systems and partner with nearly every major global pharmaceutical company. Click Here Access full stories BMS says outsourcing is 'a strategic function asset' Outsourcing has become so paramount in a pharmaceutical's infrastructure and drug discovery strategy that it can no longer be considered an option... Read Cardinal gets green light for new sterile facility start-up Cardinal Health has been given the green light from the US Food and Drug Administration (FDA) to start manufacturing the first commercial drug at its new sterile facility in North Carolina... Read Kemwell seals Pfizer plant deal Kemwell has sealed the deal on the purchase of Pfizer's Swedish manufacturing plant and at the same time secured a long-term contract manufacturing agreement with the drug giant... Read Bioinformatics outsourcing poised for growth Outsourcing is expected to emerge as a definitive trend in the bioinformatics industry, according to a new report by Frost & Sullivan... Read CROs to benefit from new trial analysis technique Contract Research Organisations involved in clinical trial services may benefit from a technique allowing researchers to analyse results of clinical trials... Read
	All News Headlines for: September | August | July
	Sponsored by SF-Chem High-quality intermediates SF-Chem is a supplier of high-quality intermediates to customers in the global chemical industry, particularly pharmaceuticals. The company is highly specialised in chlorine and sulfur chemistry. Click Here

Previous Headlines > Consolidation in Indian packag ... > Intercell's adjuvant stimulate ... > How to avoid contract manufact ... > Xceleron moves in on $1bn US t ... > Split within Amphora leads to ... > The futurea€™s brig ... > Choosing the right contract ma ... > Emergency research guidelines ... > Outsourcing demand boosts anal ... > GSK signs a $1.5bn deal with C ... Product Categories > Product & Supplier News - Contract Manufacturing Related Web Sites > In-PharmaTechnologist.com > DrugResearcher.com > BioPharmaReporter.com > All our Websites

Other top industry news Sieve advances protein separation and drug development A new technology promises to speed up the categorisation of proteins, reducing the time consuming and laborious process... Read Lean proves mean in drug manufacturing The majority of pharmaceutical manufacturers who have adopted the lean manufacturing model are not satisfied according to a new survey, raising questions about the efficacy of a system popular in the automotive... Read Will big pharma share its APIs for the sake of custom-made drugs? Britain's manufacturers of tailor-made non-licensed medicines are working on establishing a unique supply agreement with major drug firms that could serve as a model worldwide for the production of special drugs... Read Discovery could halt antibiotic resistant spread Researchers think that they have developed an effective tactic, which aims to stop the spread of bacterial infections that have become resistant to antibiotic treatment... Read Events - Publisher's Choice STAY up-to-date with pharmaceutical Innovations Visit our regularly updated events calendar and learn about important events within the industry today ... Read ELNS & Laboratory Informatics 4 days of interactive sessions and case studies providing the most current assessment of the future of electronic data recording implementation, integ ... Read Sponsored by ScinoPharm Taiwan® Experts in small molecule custom synthesis ScinoPharm Taiwan®, Ltd. is a process research, development, and manufacturing service provider of active pharmaceutical ingredients (APIs) to the global pharmaceutical industry. Our expertise is in small molecule custom synthesis. Click Here Forward to a colleague

Subscribe to other Decision News Media e-newsletters - Pharmaceuticals Breaking news Pharmaceutical Technology Drug Discovery Outsourcing Pharma Biopharmaceutical Science and Business Laboratory Equipment Access Decision News Media e-newsletters for the food, beverage & nutition industries click here

	To continue to receive this newsletter in your inbox, please add newsletter@outsourcing-pharma.com to your address book
	Update preferences | Change your email address | ***
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2006 - Decision News Media S.A.S - All Rights Reserved La Tour du Triangle - 26, allee Jules Milhau - 34000 Montpellier - France http://www.decisionnewsmedia.com

 

© 2007 - The Code Kitchen for interface design and text. Newsletter content remains the copyright of the respective publishers.
Contact: info@newsletterarchive.org